Search results for "registries"

showing 10 items of 615 documents

Cellular Phones, Cordless Phones, and the Risks of Glioma and Meningioma (Interphone Study Group, Germany)

2006

The widespread use of cellular telephones has generated concern about possible adverse health effects, particularly brain tumors. In this population-based case-control study carried out in three regions of Germany, all incident cases of glioma and meningioma among patients aged 30–69 years were ascertained during 2000–2003. Controls matched on age, gender, and region were randomly drawn from population registries. In total, 366 glioma cases, 381 meningioma cases, and 1,494 controls were interviewed. Overall use of a cellular phone was not associated with brain tumor risk; the respective odds ratios were 0.98 (95% confidence interval (CI): 0.74, 1.29) for glioma and 0.84 (95% CI: 0.62, 1.13)…

AdultMaleOncologymedicine.medical_specialtyEpidemiologyPopulationBrain tumorRisk AssessmentInterviews as TopicMeningiomaElectromagnetic FieldsRisk FactorsGermanyGliomaInternal medicineCordless phonemedicineHumansRegistriesRisk factoreducationneoplasmsAgededucation.field_of_studyBrain Neoplasmsbusiness.industryIncidenceCase-control studyEnvironmental ExposureGliomaOdds ratioMiddle Agedmedicine.diseasenervous system diseasesSurgerycellular phoneCase-Control StudiestelephoneFemaleMeningiomaRisk assessmentbusinessCell PhoneAmerican Journal of Epidemiology
researchProduct

Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century

2017

Population-level survival has increased for a number of hematologic malignancies.[1][1]–[3][2] Multiple myeloma, in particular, has seen improved survival both in clinical trials[4][3]–[8][4] and on the population level.[3][2],[9][5]–[11][6] However, it is not known whether the changes in

AdultMalePathologymedicine.medical_specialtyAdolescentPopulationImproved survivalLymphoplasmacytic Lymphoma03 medical and health sciencesYoung Adult0302 clinical medicineGermanymedicineHumansRegistrieseducationOnline Only ArticlesMultiple myelomaAgededucation.field_of_studybusiness.industryHematologyMiddle Agedmedicine.diseaseUnited StatesSurvival Rate030220 oncology & carcinogenesisPopulation SurveillanceFemaleWaldenstrom MacroglobulinemiabusinessSolitary plasmacytoma030215 immunologyPlasmacytomaSEER Program
researchProduct

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.

2014

More effective treatments have become available for haematological malignancies from the early 2000s, but few large-scale population-based studies have investigated their effect on survival. Using EUROCARE data, and HAEMACARE morphological groupings, we aimed to estimate time trends in population-based survival for 11 lymphoid and myeloid malignancies in 20 European countries, by region and age.In this retrospective observational study, we included patients (aged 15 years and older) diagnosed with haematological malignancies, diagnosed up to Dec 31, 2007, and followed up to Dec 31, 2008. We used data from the 30 cancer registries (across 20 countries) that provided continuous incidence and …

AdultMalePathologymedicine.medical_specialtyAdolescentPopulationRisk AssessmentSeverity of Illness IndexDisease-Free SurvivalNOCohort StudiesYoung AdultCause of DeathConfidence IntervalsHematologic Neoplasms/diagnosis/mortality/therapyMedicineHumansRegistrieseducationSurvival analysisddc:613Cause of deathAgedRetrospective Studieseducation.field_of_studyRelative survivalbusiness.industryIncidence (epidemiology)Absolute risk reductionRetrospective cohort studyMiddle AgedCombined Modality TherapySurvival AnalysisEuropeOncologyHematologic NeoplasmsFemalebusinessDemographyCohort studyThe Lancet. Oncology
researchProduct

Strategy for Long-Term Surveillance at the German Childhood Cancer Registry - an Update

2011

Background The objective of this paper is to provide information about the quality (e.g. completeness, response) of long-term surveillance in German paediatric oncology and haematology based on the structures implemented by the German Childhood Cancer Registry (GCCR). Methods The GCCR contacts parents or patients to collect and update information on a minimal set of follow-up health status data (e.g. late relapses, subsequent neoplasms, current address) and exchanges this information regularly with the appropriate clinical trials. Results Between 2006 and 2010, GCCR approached a total of about 20,000 patients (contact at the age of 16 years, inquiry concerning the health status) in the cont…

AdultMalePediatricsmedicine.medical_specialtyAdolescentDatabases FactualLymphomaCross-sectional studyHealth StatusMEDLINECentral Nervous System NeoplasmsCohort StudiesGermanYoung AdultCause of DeathGermanyNeoplasmsHumansMedicineRegistriesSurvivorsYoung adultChildClinical Trials as TopicChildhood Cancer RegistryLeukemiabusiness.industryMiddle AgedLong-Term CareSurvival Analysislanguage.human_languageClinical trialLong-term careCross-Sectional StudiesChild PreschoolPopulation SurveillanceFamily medicinePediatrics Perinatology and Child HealthQuality of LifelanguageFemalebusinessCohort studyKlinische Pädiatrie
researchProduct

Association of childhood cancer with factors related to pregnancy and birth

1999

It has been hypothesized that risk factors of childhood cancers may already operate during the prenatal and neonatal period. Results of previous epidemiological studies have been inconsistent.During 1992-1997 a large case-control study on childhood cancers and a variety of potential risk factors was conducted in Germany. Cases were ascertained by the German Childhood Cancer Registry. Each case was matched to a population-based control of the same age and gender, sampled from the district where the case lived at the date of diagnosis. For the analyses, 2358 cases and 2588 controls were available.Risk of childhood acute leukaemia increased with maternal ageor =20 years at time of delivery (od…

AdultMalePediatricsmedicine.medical_specialtyAdolescentHormone Replacement TherapyEpidemiologyBirth weightPopulationBone NeoplasmsSoft Tissue NeoplasmsPrenatal careCentral Nervous System NeoplasmsPregnancyRisk FactorsGermanyOdds RatiomedicineBirth WeightHumansRegistriesRisk factorChildeducationRetrospective Studieseducation.field_of_studyChildhood Cancer RegistryPregnancybusiness.industryLymphoma Non-HodgkinSmokingInfant NewbornCase-control studyInfantGeneral MedicineOdds ratioPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.diseaseParityMaternal ExposureChild PreschoolPrenatal Exposure Delayed EffectsFemalebusinessMaternal AgeInternational Journal of Epidemiology
researchProduct

Safety of potential breast milk exposure to IFN-β or glatiramer acetate

2019

ObjectiveTo determine whether potential breast milk exposure to interferon-beta (IFN-β) or glatiramer acetate (GA) is safe for the infant.MethodsWe identified 74 infants born to 69 women with MS who breastfed under IFN-β (n = 39), GA (n = 34), or both (n = 1). Women had been enrolled into the German Multiple Sclerosis and Pregnancy Registry during pregnancy. Data were obtained from standardized, telephone-administered questionnaires completed by the mother during pregnancy and at 1, 3, 6, and 12 months postpartum and the infant's take-home medical record.ResultsThe median duration of exposed breastfeeding was 8.5 months (wide interquartile range: 4.9–12.7 months). Physical growth curves dur…

AdultMalePediatricsmedicine.medical_specialtyMultiple Sclerosis41BreastfeedingBreast milkArticleChild DevelopmentPregnancyInterquartile rangemedicineHumansImmunologic FactorsRegistriesGlatiramer acetatePregnancyMilk Humanbusiness.industryPostpartum PeriodInfantGlatiramer AcetateInterferon-betamedicine.disease54Pregnancy ComplicationsBreast FeedingNeurologyFemaleMedian bodyNeurology (clinical)businessBreast feedingPostpartum periodmedicine.drugNeurology - Neuroimmunology Neuroinflammation
researchProduct

Second Malignancies Following Childhood Cancer Treatment in Germany From 1980 to 2014.

2018

BACKGROUND Because of improvements in cancer treatment, more than 80% of all children with cancer now survive at least five years from the time of diagnosis. As a result, late sequelae of cancer and its treatment have become more common, particularly second malignancies. We studied the current incidence of second malignancies among childhood cancer survivors in Germany. METHODS This study is based on the cohort of the German Childhood Cancer Registry (Deutsches Kinderkrebsregister, DKKR). Persons given the diagnosis of a first malignancy at any time in the years 1980-2014 who were no more than 14 years old at the time of diagnosis and survived at least six months thereafter were included in…

AdultMalePediatricsmedicine.medical_specialtyPopulationMalignancy03 medical and health sciencesYoung Adult0302 clinical medicineCancer SurvivorsRisk FactorsGermanymedicineHumansCumulative incidence030212 general & internal medicineRegistrieseducationChildProportional Hazards Modelseducation.field_of_studyChildhood Cancer Registrybusiness.industryIncidence (epidemiology)IncidenceHazard ratioCancerNeoplasms Second PrimaryGeneral MedicineMiddle Agedmedicine.diseaseAdult Survivors of Child Adverse Events030220 oncology & carcinogenesisCohortFemaleOriginal ArticlebusinessDeutsches Arzteblatt international
researchProduct

Latvian registry of familial hypercholesterolemia: The first report of three-year results.

2018

Abstract Background and aims Familial hypercholesterolemia (FH) was rarely diagnosed in Latvia before 2015, when the Latvian Registry of FH (LRFH) was established. Here, we report the first experience of the LRFH over three years (2015–2017). Methods The LRFH is an ongoing nationwide, dynamic, long-term prospective cohort. The diagnosis of FH was assessed using the Dutch Lipid Clinic Network (DLCN) criteria. Cascade screening of first-degree relatives using age- and sex-specific percentiles of low-density lipoprotein cholesterol (LDL-C) was performed in relatives of patients with definite and probable FH. Results Among the 416 individuals included in the LRFH, 181 patients were diagnosed wi…

AdultMalePediatricsmedicine.medical_specialtyStatinHeredityTime Factorsmedicine.drug_classDown-RegulationCascade screeningFamilial hypercholesterolemia030204 cardiovascular system & hematologyRisk AssessmentHyperlipoproteinemia Type II03 medical and health sciences0302 clinical medicineRisk FactorsmedicineHumansGenetic Predisposition to Disease030212 general & internal medicineProspective StudiesRegistriesProspective cohort studyLipid clinicLipoprotein cholesterolAgedbusiness.industryAnticholesteremic AgentsMean ageCholesterol LDLMiddle Agedmedicine.diseaseLatviaCoronary heart diseasePedigreePhenotypeTreatment OutcomeCardiovascular DiseasesDrug Therapy CombinationFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersAtherosclerosis
researchProduct

Migraine history and migraine-induced stroke in the Dijon stroke registry.

1999

Two thousand three hundred and eighty-nine patients with first-ever stroke were registered in the population-based Dijon Stroke Registry over an 11-year period. There was a history of migraine in 49 cases (2%), with a majority of women (2.8% versus 1.1% men) with the following distribution: 27 cases among 1,380 large-artery cerebral infarctions (1.9%), 6 cases among 358 small-artery cerebral infarctions (1.6%), 6 cases among 412 cerebral infarctions due to cardiac embolism (1.4%), 7 cases among 191 cerebral hemorrhages (3.6%) and 3 cases among 47 subarachnoid hemorrhages (6.3%). The male/female ratio was 0.58 for the 49 strokes with a history of migraine versus 1.27 for the 2,340 strokes wi…

AdultMalePediatricsmedicine.medical_specialtyStroke registryAdolescentEpidemiologyMigraine DisordersPopulationInfarctionCatchment Area HealthRecurrenceRisk FactorsEpidemiologyMedicineHumanscardiovascular diseasesProspective StudiesRegistrieseducationStrokeeducation.field_of_studybusiness.industryIncidence (epidemiology)Middle Agedmedicine.diseaseConfidence intervalCerebrovascular DisordersMigraineCommunity MedicineAnesthesiaPopulation SurveillanceFemaleNeurology (clinical)FrancebusinessNeuroepidemiology
researchProduct

A retrospective follow up study on maternal age and infant mortality in two Sicilian districts

2011

Abstract Background Infant mortality rate (IMR) is a key public health indicator. Maternal age is a well-known determinant of pregnancy and delivery complications and of infant morbidity and mortality. In Italy the Infant Mortality Rate was 3.7/1000 during 2005, lower than the average IMR for the European Union (4.94/1000). Sicily is the Italian region with the highest IMR, 5/1000, and neonatal mortality rate (NMR), 3.8/1000, with substantial variation among its nine districts. The present study compared a high IMR/NMR district (Messina) with a low IMR/NMR district (Palermo) during the period 2004-2006 to evaluate potential determinants of the IMRs' differences between the two districts and…

AdultMalePediatricsmedicine.medical_specialtyretrospective studySettore MED/42 - Igiene Generale E Applicatasymbols.namesakeEpidemiologyInfant Mortalitymedicinemedia_common.cataloged_instanceHumansAdvanced maternal agePoisson regressioninfant mortality rateRegistriesEuropean unionSicilymedia_commonRetrospective StudiesPregnancybusiness.industrylcsh:Public aspects of medicinePublic healthPublic Health Environmental and Occupational HealthInfant NewbornInfantlcsh:RA1-1270medicine.diseaseInfant mortalitysymbolsFemaleLive birthbusinessDemographyResearch ArticleFollow-Up StudiesMaternal AgeBMC Public Health
researchProduct